Sofinnova Ventures »

Novartis shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Novartis (NVS) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Novartis

Tip: Access up to 7 years of quarterly data

All positions including Novartis held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novartis by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-09-30 $23M 200k 115.02

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Novo-Nordisk A S Adr (NVO)
AstraZeneca Sponsored Adr (AZN)
Ideaya Biosciences (IDYA)
Elanco Animal Health (ELAN)
Bioage Labs
Axsome Therapeutics Put Option (AXSM)
Incyte Corporation (INCY)
Soleno Therapeutics (SLNO)
Rapport Therapeutics (RAPP)
Arrivent Biopharma (AVBP)
Y Mabs Therapeutics (YMAB)
Dyne Therapeutics (DYN)
Cogent Biosciences (COGT)

View all positions for Sofinnova Ventures

Top funds holding Novartis

Dodge & Cox
PRIMECAP Management Company
Dimensional Fund Advisors
Morgan Stanley
Bank of America Corporation
Franklin Resources
Goldman Sachs Group
Henderson Group
Principal Financial Group
Renaissance Technologies
Cullen Capital Management
Wells Fargo & Company
Envestnet Asset Management
BlackRock
BlackRock

View all funds holding Novartis